Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

TRUH vs. QAAGZX: which is better?

Bottom line

TRUH vs QAAGZX: the short answer

TRUH (VanEck Healthcare TruSector ETF) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 80% by weight.

But QAAGZX is far broader, holding 277 positions to 60 for TRUH, so beyond the top names it adds exposure TRUH doesn't have.

TRUH is cheaper at 0.1% vs 0.86% — a difference of $76 a year per $10,000 invested.

Updated Nov 19, 2026

TRUH vs QAAGZX side by side

TRUHQAAGZX
TypeETFETF
Fund familyVanEckT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.1%0.86%
Annual cost per $10k$10$86
10-yr cost on $10k (prospectus)—$1,061
Max front loadNoneNone
12b-1 fee—0%
1-yr return—+18.1%
5-yr return (annualized)—+4.1%
10-yr return (annualized)—+9.0%
Best quarter—+23.4%
Worst quarter—−15.8%
Net assets (fund)$833.1K$751.7M
Number of holdings60277
Portfolio turnover—65%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

17 of TRUH's top 25 holdings also appear in QAAGZX's top 25.

Shared top holdings
HoldingTRUHQAAGZX
Eli Lilly & Co16.56%14.06%
Johnson & Johnson10.67%6.64%
AbbVie Inc7.76%5.12%
UnitedHealth Group Inc6.59%5.88%
Merck & Co Inc5.54%4.00%
Amgen Inc3.39%1.80%
Thermo Fisher Scientific Inc3.25%2.53%
Abbott Laboratories2.76%1.91%
Gilead Sciences Inc2.74%2.79%
Intuitive Surgical Inc2.48%1.89%
CVS Health Corp2.31%0.93%
Vertex Pharmaceuticals Inc2.21%2.26%
Danaher Corp2.10%1.44%
Bristol-Myers Squibb Co2.05%2.12%
Stryker Corp1.89%1.78%

Source: SEC Form N-PORT

TRUH top 10

  1. Eli Lilly & Co — 16.56%
  2. Johnson & Johnson — 10.67%
  3. AbbVie Inc — 7.76%
  4. UnitedHealth Group Inc — 6.59%
  5. Merck & Co Inc — 5.54%
  6. Amgen Inc — 3.39%
  7. Thermo Fisher Scientific Inc — 3.25%
  8. Abbott Laboratories — 2.76%
  9. Gilead Sciences Inc — 2.74%
  10. Intuitive Surgical Inc — 2.48%

QAAGZX top 10

  1. Eli Lilly & Co — 14.06%
  2. Johnson & Johnson — 6.64%
  3. Unitedhealth Group Inc — 5.88%
  4. Abbvie Inc — 5.12%
  5. Merck & Co. Inc. — 4.00%
  6. Gilead Sciences Inc — 2.79%
  7. Thermo Fisher Scientific Inc — 2.53%
  8. Vertex Pharmaceuticals Inc — 2.26%
  9. Bristol-myers Squibb Co — 2.12%
  10. Abbott Laboratories — 1.91%

FAQ

What is the difference between TRUH and QAAGZX?
TRUH (VanEck Healthcare TruSector ETF) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 80% by weight. But QAAGZX is far broader, holding 277 positions to 60 for TRUH, so beyond the top names it adds exposure TRUH doesn't have.
Which is cheaper, TRUH or QAAGZX?
TRUH has the lower expense ratio (0.1%).
Should I own both TRUH and QAAGZX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.